| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,480 | 2,560 | 07:00 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.08.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 29.08.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 29.08.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 29.08.2024ISIN NameCA00547K1057 ADAMANT... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.10.24 | Avant Brands Inc (2): Avant omits P&L from Q3 NR, talks adj. net income | ||
| 15.10.24 | Avant Brands reports Q3 results | ||
| 15.10.24 | Avant Brands Inc.: Avant Brands Announces Results for Q3 2024 | Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new company records.Record Export Wholesale Revenue1: Generated $5.1 million... ► Artikel lesen | |
| 23.09.24 | Avant Brands Inc (2): Avant Brands signs BLK MKT licensing deal for Australia | ||
| 23.09.24 | Avant Brands Inc.: Avant Brands Expands Global Footprint with BLK MKT Launch in Australia | KELOWNA, BC and MELBOURNE, AUSTRALIA / ACCESSWIRE / September 23, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading Canadian producer of award-winning... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22:02 | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando | BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| 05.02. | Sonoma Pharmaceuticals GAAP EPS of -$0.63 beats by $0.06, revenue of $3.6M misses by $0.46M | ||
| 05.02. | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results | Revenues increased 14% for the quarter compared to prior year and 13% year-to-datePositive cash flow from operations for the quarter with $5.2 million of cash at December 31, 2024Year-to-date net loss... ► Artikel lesen | |
| 05.02. | Sonoma Pharmaceuticals, Inc. - 10-Q, Quarterly Report | ||
| 30.01. | Sonoma Pharmaceuticals, Inc. - 8-K, Current Report |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ADAMANT HOLDING INC | - | - |
| AVANT BRANDS INC | 0,800 | -9,09 % |
| SONOMA PHARMACEUTICALS INC | 2,520 | -100,00 % |
